- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06128304
ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services (ACCESS)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Gregory Aarons, PhD
- Phone Number: +1 8583350700
- Email: gaarons@health.ucsd.edu
Study Contact Backup
- Name: Echezona Ezeanolue, MD, MPH
- Phone Number: +234 803 773 9972
- Email: echezona.ezeanolue@unn.edu.ng
Study Locations
-
-
-
Enugu, Nigeria
- Recruiting
- University of Nigeria, Nsukka
-
Contact:
- Echezona Ezeanolue, MD, MPH
- Phone Number: +1 7024991082
- Email: echezona.ezeanolue@unn.edu.ng
-
Contact:
- Tonia Onyeka
- Phone Number: +234 806 356 3223
- Email: tonia.onyeka@unn.edu.ng
-
-
-
-
California
-
La Jolla, California, United States, 92093
- Recruiting
- UC San Diego
-
Contact:
- Joella Phillips, BA
- Phone Number: 2695 858-966-7703
- Email: jiphillips@ucsd.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Women living with HIV
Exclusion Criteria:
-
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Core Implementation Strategies
Core Implementation Strategies
|
Core Implementation Strategies
Includes all of the Core implementation strategies and adds: 5. Community engagement using Health Beginning Initiative Model 6. Smart Cards to facilitate patient engagement |
Experimental: Core+ Enhanced Implementation Strategies
Includes all of the Core implementation strategies and adds: 5. Community engagement using Health Beginning Initiative Model 6. Smart Cards to facilitate patient engagement |
Includes all of the Core implementation strategies and adds: 5. Community engagement using Health Beginning Initiative Model 6. Smart Cards to facilitate patient engagement |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Reach
Time Frame: 12 months after enrollment
|
Percent of WLHIV who had cervical cancer (CC) screening
|
12 months after enrollment
|
Sustainment
Time Frame: 3 months prior to study completion
|
Provider Report of Sustainment Scale (PRESS; Moullin et al., 2021).
The PRESS has 3-items scored from 0 "not at all" to 4 "to a very great extent" where higher scores indicate better evidence-based practice sustainment.
|
3 months prior to study completion
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
CCST Effectiveness
Time Frame: 15 months after treatment of pre-invasive cancer
|
Percent of WLHIV treated for pre-invasive cancer who had negative post treatment follow-up screen
|
15 months after treatment of pre-invasive cancer
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Gregory Aarons, PhD, University of California, San Diego
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Neoplasms
- Urogenital Neoplasms
- Neoplasms by Site
- Uterine Neoplasms
- Genital Neoplasms, Female
- Uterine Cervical Diseases
- Uterine Diseases
- Female Urogenital Diseases
- Female Urogenital Diseases and Pregnancy Complications
- Urogenital Diseases
- Genital Diseases
- Genital Diseases, Female
- Uterine Cervical Neoplasms
Other Study ID Numbers
- U01CA275118 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cervical Cancer
-
University of California, San DiegoWithdrawnCervical Cancer | Cervical Cancer Stage | Cervical Cancer Stage IB2 | Cervical Cancer Stage IB1 | Cervical Cancer Stage I | Cervical Cancer Stage IB | Cervical Cancer Stage II | Cervical Cancer Stage IIa | Cervical Cancer, Stage IIB | Cervical Cancer, Stage III | Cervical Cancer Stage IIIB | Cervical Cancer... and other conditionsUnited States
-
M.D. Anderson Cancer CenterWithdrawnStage IB3 Cervical Cancer FIGO 2018 | Stage II Cervical Cancer FIGO 2018 | Stage IIA Cervical Cancer FIGO 2018 | Stage IIA1 Cervical Cancer FIGO 2018 | Stage IIA2 Cervical Cancer FIGO 2018 | Stage IIB Cervical Cancer FIGO 2018 | Stage III Cervical Cancer FIGO 2018 | Stage IIIA Cervical Cancer FIGO... and other conditions
-
Abramson Cancer Center of the University of PennsylvaniaWithdrawnCervical Cancer | Stage IB Cervical Cancer | Stage IIA Cervical Cancer | Stage IIB Cervical Cancer | Stage III Cervical Cancer | Stage IVA Cervical Cancer
-
National Cancer Institute (NCI)CompletedCervical Adenocarcinoma | Cervical Squamous Cell Carcinoma | Stage IB Cervical Cancer | Stage IIA Cervical Cancer | Stage IIB Cervical Cancer | Stage III Cervical Cancer | Stage IVA Cervical Cancer | Stage IVB Cervical CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingStage IA Cervical Cancer | Stage IB Cervical Cancer | Stage IA1 Cervical Cancer | Stage IA2 Cervical Cancer | Stage IB1 Cervical Cancer | Stage IB2 Cervical Cancer | Stage IB3 Cervical CancerUnited States
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingCervical Adenosquamous Carcinoma | Cervical Squamous Cell Carcinoma, Not Otherwise Specified | Recurrent Cervical Carcinoma | Stage IB3 Cervical Cancer FIGO 2018 | Stage II Cervical Cancer FIGO 2018 | Stage IIA Cervical Cancer FIGO 2018 | Stage IIA1 Cervical Cancer FIGO 2018 | Stage IIA2 Cervical... and other conditionsUnited States
-
Shanghai First Maternity and Infant HospitalNot yet recruitingCervical Cancer, Stage IIB | Cervical Cancer Stage IIIB | Cervical Cancer Stage IIIA | Cervical Cancer, Stage IVA
-
University of Southern CaliforniaNational Cancer Institute (NCI)CompletedRecurrent Cervical Cancer | Stage IVA Cervical Cancer | Stage IVB Cervical Cancer | Stage IIIA Cervical Cancer | Stage IIIB Cervical CancerUnited States
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedCervical Adenocarcinoma | Cervical Squamous Cell Carcinoma | Stage IB Cervical Cancer | Stage IIA Cervical Cancer | Stage IIB Cervical Cancer | Stage III Cervical Cancer | Stage IVA Cervical CancerUnited States
-
Institut de Cancérologie de LorraineCompletedCervical Adenocarcinoma | Stage IB Cervical Cancer | Stage III Cervical Cancer | Stage II Cervical CancerFrance
Clinical Trials on Core Implementation strategies
-
University of North Carolina, Chapel HillNational Center for Complementary and Integrative Health (NCCIH)Enrolling by invitation
-
National Center for Chronic and Noncommunicable...World Health OrganizationEnrolling by invitationHypertension | Diabetes Mellitus, Type 2China
-
Karolinska InstitutetCompleted
-
Washington University School of MedicineRecruitingBehavior | Process, Acceptance | Inertia of AccommodationUnited States
-
Harvard School of Public Health (HSPH)National Cancer Institute (NCI); National Institutes of Health (NIH)CompletedBreast Cancer Screening | Implementation | Colorectal Cancer ScreeningUnited States
-
Corporacion Parc TauliHospital Clinic of Barcelona; Instituto de Salud Carlos III; Institut Catala...Unknown
-
Mayo ClinicEnrolling by invitationCardiovascular Risk | Cardiovascular PreventionUnited States
-
University of IowaUniversity of Washington; University of MinnesotaCompletedImplementation Science | Child Behavior Disorders | Healthcare Providers | Adolescent Problem Behavior at School
-
University of PittsburghNational Institute of Mental Health (NIMH); University of Michigan; NYU Langone... and other collaboratorsRecruitingAttention Deficit and Disruptive Behavior Disorders | Child Behavior ProblemUnited States
-
Bryan KutnerNational Institute of Mental Health (NIMH); Albert Einstein College of Medicine and other collaboratorsEnrolling by invitationPatient Engagement | Human Immunodeficiency Virus | Stigma, SocialUnited States